96713 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being basic the first amino acid being Arg
BETA-PEPTIDES AND BETA-PEPTIDE HYDROGELS
#2CRYSTALLINE SALT FORMS
#3PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#4TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#5METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#6PEPTIDE COMPOSITIONS CAPABLE OF BINDING LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF
#7MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION
#8METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#9AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#10AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#11TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#12MODIFIED TRIPEPTIDES FOR USE IN THE TREATMENT OF A NON-ENVELOPED VIRUS INFECTION
#13PSMA-TARGETED NIR DYES AND THEIR USES
#14COSMETIC PEPTIDES FOR IMPROVING SKIN REJUVENATION
#15PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE
#16COMPOUNDS FOR USE IN THE TREATMENT OF AN ENVELOPED VIRUS INFECTION
#17TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#18MITOCHONDRIA-TARGETING PEPTIDES
#19PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME
#20Methods and compositions for preventing or treating ophthalmic conditions
#21METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#22Nanobarcode for controlling cell adhesion and differentiation of stem cells, preparation method thereof, and method of controlling adhesion and differentiation of stem cells by using the same
#23Methods for the prevention or treatment of heart failure
#24Crystalline salt forms
#25Mitochondria-targeting peptides
#26METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#27PEPTIDE ACETALS FOR STABILISING ENZYMES
#28INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#29PEPTIDE FOR REDUCING HAIR LOSS AND PROMOTING HAIR GROWTH, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#30PSMA-TARGETED NIR DYES AND THEIR USES
#31Transfection complexes and methods of using the same
#32GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#33PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#34METHOD FOR THE STEREOISOMERIZATION OF CHIRAL COMPOUNDS
#35Nanobarcode for controlling cell adhesion and differentiation of stem cells
#36Method of controlling adhesion and polarization of macrophages by using nanobarcode
#37CELL LINKERS FOR HETEROTYPIC CELL SPHEROIDS
#38LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#39Methods for the synthesis of arginine-containing peptides
#40PEPTIDES OF USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA
#41METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#42ANABOLIC TARGETING STEM CELL GENE THERAPY FOR OSTEOPOROSIS
#43Methods and compositions for preventing or treating ophthalmic conditions
#44AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#45Antimicrobial compounds
#46Modified peptides for use in treating neurodegenerative disorders
#47Crystalline salt forms
#48PSMA-targeted NIR dyes and their uses
#49Aromatic-cationic peptides and uses of same
#50Peptide therapies for reduction of macular thickening
#51PEPTIDE COMPOSITIONS AND RELATED METHODS
#52LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#53PEPTIDE COMPOSITIONS AND RELATED METHODS
#54Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#55Peptide inhibitors of tight junction permeability
#56Aromatic-cationic peptides and methods for using same
#57Methods for the prevention or treatment of heart failure
#58METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#59Interferon Analogs
#60Crystalline salt forms
#61METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#62Matriptase inhibitors and uses thereof
#63PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#64AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#65Peptides useable for treating cancer
#66PROCESS FOR PREPARATION OF ICATIBANT ACETATE
#67ANTIMICROBIAL COMPOUNDS
#68GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#69Targeted prodrug cytosine deaminase fusion carrier and application thereof
#70N-carboxyanhydride-based-scale synthesis of elamipretide
#71PSMA-targeted NIR dyes and their uses
#72Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells
#73AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#74Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#75THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#76AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#77Transfection complexes and methods of using the same
#78AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME
#79Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers
#80Interferon analogs
#81Peptides of use in the preventive and curative treatment of alopecia
#82METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#83Chromogenic And Fluorogenic Peptide Substrates For The Detection Of Serine Protease Activity
#84Compositions and methods for inhibition of bacterial infections in human endocervix
#85Inhibition of gliadin peptides
#86NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#87Inhibitors of growth factor activation enzymes
#88Bioactive nanofiber cyto-scaffold
#89Chemical synthesis and screening of bicyclic peptide libraries
#90Methods and compositions for preventing or treating ophthalmic conditions
#91PSMA—targeted NIR dyes and their uses
#92Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#93PSMA-targeted NIR dyes and their uses
#94Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#95Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
#96AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#97Smart Pro-Drugs of Serine Protease Inhibitors
#98Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#99Use of a tetraphenylborate (TPB) salt for the separation of biomolecules
#100LLP2A-bisphosphonate conjugates for osteoporosis treatment
#101ANTIMICROBIAL COMPOUNDS
#102INHIBITION OF GLIADIN PEPTIDES
#103Bispecific peptide conjugate and radioactive bispecific peptide imaging agent
#104PSMA-targeted NIR dyes and their uses
#105PSMA-targeted NIR dyes and their uses
#106Dual targeting drug carrier and application thereof
#107USE OF AROMATIC-CATIONIC PEPTIDES TO TREAT CHOLESTEROL-INDUCED MITOCHONDRIAL DYSFUNCTION
#108AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#109Pro-angiogenic peptides and peptide conjugates
#110Interferon Analogs
#111ASSAY FOR INSULIN-DEGRADING ENZYME (IDE) INHIBITORS
#112METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#113NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#114Composition comprising neural cell and elastin-like polypeptide for treating Parkinson's disease
#115Methods and compositions for the treatment of axonal and neuronal degeneration
#116Short peptides and a method of use as an antioxidant
#117Chemical synthesis and screening of bicyclic peptide libraries
#118Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#119Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#120LLP2A-bisphosphonate conjugates for osteoporosis treatment
#121Liquid automatic dish washing detergent compositions
#122Methods and compositions for preventing or treating ophthalmic conditions
#123Tunable control of protein degradation in synthetic and endogenous bacterial systems
#124Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#125Short peptides and a method of use as an antioxidant
#126Tetrapeptides and a method of use as an antioxidant
#127Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#128Peptides having NF-κB inhibitory activity, or composition comprising same
#129Tripeptide rhodamine compound
#130Prodrugs for selective anticancer therapy
#131INHIBITION OF GLIADIN PEPTIDES
#132Peptides and use thereof
#133HCV protease inhibitors and uses thereof
#134Substrates and inhibitors of prolyl oligopeptidase and methods of use
#135Inhibitors of Furin and other pro-protein convertases
#136AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#137Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
#138AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#139AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#140Aromatic-cationic peptides and methods for using same
#141Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#142AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#143Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#144LLP2A-bisphosphonate conjugates for osteoporosis treatment
#145Methods and compositions for preventing or treating ophthalmic conditions
#146RGD mimetic γ-AApeptides and methods of use
#147Methods and compositions for the treatment of axonal and neuronal degeneration
#148HCV protease inhibitors and uses thereof
#149Smart pro-drugs of serine protease inhibitors
#150TARGETING COMPOUNDS
#151Integrin receptor antagonists and their methods of use
#152Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#153Interferon analogs
#154AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#155C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#156AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#157SERINE HYDROLASE FORMULATION
#158Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
#159Iodine radiolabelling method
#160Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same
#161HCV protease inhibitors and uses thereof
#162PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS
#163Method of treating tumors
#164ANGIOGENESIS INDUCING AGENT COMPRISING RECOMBINANT GELATIN
#165Method of treatment of bacterial infection by administration of poly-lysine
#166Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#167Substrate peptide sequences for plague plasminogen activator and uses thereof
#168VEGFR-1/NRP-1 TARGETING PEPTIDES
#169VAULT AGENTS FOR CHRONIC KIDNEY DISEASE
#170ANTIOXIDANT AGENT
#171N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic
#172Antimicrobial compounds
#173Inhibition of gliadin peptides
#174FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#175Method of treatment of non-dermatophytic fungal infections
#176Oligomeric biosurfactants in dermatocosmetic compositions
#177Treatment of biofilms
#178Methods and compositions for preventing or treating ophthalmic conditions
#179Antimicrobial compounds
#180Fluorine-labeled compounds
#181Use of a tetraphenylborate (TPB) salt for the separation of biomolecules
#182Peptide manufacturing process
#183METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#184Collagen peptide conjugates and uses therefor
#185Inhibitors of mammalian tight junction opening
#186Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails
#187Stabilized liquid enzyme compositions
#188Method of treatment of a fungal infection with poly arginine peptides
#189BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#190PEPTIDE GAP JUNCTION MODULATORS
#191METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#192POLYPEPTIDE
#193RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM
#194Antimicrobial compounds and formulations
#195Modulation of platelet aggregation
#196Radiofluorination methods
#197Smart Pro-Drugs of Serine Protease Inhibitors
#198Endothelium mimicking nanomatrix
#199Peptides Inhibiting Angiotensin-Converting Enzyme
#200HCV protease inhibitors and uses thereof
#201INHIBITION OF ALPHA-SYNUCLEIN AGGREGATION
#202Treatment methods using peptides related to amyloid precursor protein
#203NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#204Methionine aminopeptidase-2 inhibitors and methods of use thereof
#205COMPOUND HAVING PHOTOSENSITIZATION ACTIVITY, PHOTOELECTRODE, AND PHOTOSENSITIZATION-TYPE SOLAR CELL
#206Anti-cancer compounds
#207POLYPEPTIDE
#208Substrate peptide sequences for plague plasminogen activator and uses thereof
#209Biochemical method for specific protein labeling
#210C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#211Imaging compounds, methods of making imaging compounds, methods of imaging, therapeutic compounds, methods of making therapeutic compounds, and methods of therapy
#212METHODS OF MAKING AND USING SURFACTANT POLYMERS
#213Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
#214Treatment methods using polypeptides related to amyloid precursor protein
#215Fluorine-labeled compounds
#216CONJUGATES OF RGD PEPTIDES AND PORPHYRIN OR (BACTERIO) CHLOROHYLL PHOTOSYNTHESIZERS AND THEIR USES
#217Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#218Peptide based-compounds
#219Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
#220Collections of Traceable Compounds and Uses Thereof
#221Methods for treatment of a dermatophytic fungal infection
#222Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#223Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#224Methods for the synthesis of arginine-containing peptides
#225Methods and compositions for pharmacologially controlled targeted immunotherapy
#226Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#227Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#228Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#229Polypeptide
#230Methionine aminopeptidase-2 inhibitors and methods of use thereof
#231Peptides promoting cell adherence, growth and secretion
#232Therapeutic agents and methods of use thereof for the treatment of melanoma
#233Anti-cancer compounds
#234Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#235Smart pro-drugs of serine protease inhibitors
#236Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#237TF binding compounds
#238Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
#239Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#240Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#241Methionine aminopeptidase-2 inhibitors and methods of use thereof
#242Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#243Methods of making and using surfactant polymers